Pacira BioSciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pacira BioSciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Pacira BioSciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $56.3M, a 14.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $56.3M -$9.57M -14.5% Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $58.6M -$9.46M -13.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $61M -$9.86M -13.9% Dec 31, 2023 10-Q 2024-07-30
Q3 2023 $63.4M -$6.27M -9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $65.8M -$6.25M -8.66% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $68.1M -$6.19M -8.33% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $70.9M -$5.53M -7.24% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $69.7M -$128K -0.18% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $72.1M +$830K +1.17% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $74.3M +$1.38M +1.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $76.4M +$1.92M +2.58% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $69.8M -$6.26M -8.23% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $71.3M -$6.55M -8.42% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $72.9M +$35.3M +93.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $74.5M +$36.4M +95.4% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $76M +$40.3M +113% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $77.8M +$41.3M +113% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $37.6M +$10.9M +40.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $38.1M +$38.1M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $35.8M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $36.5M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $26.7M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.